These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3580108)

  • 1. Neonatal administration of vasopressin antiserum induces long-term deficits on active and passive avoidance behaviour in rats.
    Moratalla R; Borrell J; Sanchez-Franco F; Del Rio J
    Behav Brain Res; 1987 Mar; 23(3):231-7. PubMed ID: 3580108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of neonatal administration of vasopressin on cardiac and behavioral responses to emotional stress in adult male rats.
    Buwalda B; Nyakas C; Koolhaas JM; Bohus B
    Physiol Behav; 1991 Nov; 50(5):929-32. PubMed ID: 1805283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-related memory effects of vasopressin analogues in rats.
    Gaffori OJ; De Wied D
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1125-9. PubMed ID: 3809214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can vasopressin alone act as an unconditioned stimulus to produce passive avoidance behaviour in rats in a typical memory experiment?
    Ebenezer IS
    Neuropharmacology; 1988 Sep; 27(9):903-7. PubMed ID: 3185866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of ACTH4-10, DG-AVP, and DG-OXT on heart rate and passive avoidance behavior in rats.
    Wan R; Diamant M; de Jong W; de Wied D
    Physiol Behav; 1992 Mar; 51(3):507-13. PubMed ID: 1326112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microinjection of anti-vasopressin serum into hippocampus in mice: effects on appetitively reinforced task after intraventricular administration of Arg-vasopressin.
    Alescio-Lautier B; Metzger D; Devigne C; Soumireu-Mourat B
    Brain Res; 1989 Oct; 500(1-2):287-94. PubMed ID: 2605497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitation of memory consolidation by vasopressin: mediation by terminals of the dorsal noradrenergic bundle?
    Kovács GL; Bohus B; Versteeg DH
    Brain Res; 1979 Aug; 172(1):73-85. PubMed ID: 466468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microinjection of arginine8-vasopressin antiserum into the dorsal hippocampus attenuates passive avoidance behavior in rats.
    Kovács GL; Buijs RM; Bohus B; van Wimersma Greidanus TB
    Physiol Behav; 1982 Jan; 28(1):45-8. PubMed ID: 7079322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Facilitation of arginine-vasopressin analogs on learning and memory in rats].
    Liu RY; Lin C; Du YC
    Zhongguo Yao Li Xue Bao; 1990 Mar; 11(2):97-100. PubMed ID: 2275398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of arginine-vasopressin in cerebrospinal fluid during passive avoidance behavior in rats.
    Laczi F; Gaffori O; Fekete M; de Kloet ER; de Wied D
    Life Sci; 1984 Jun; 34(24):2385-91. PubMed ID: 6727572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressin and memory: the influence of prior experience with the training situation.
    Rigter H
    Behav Neural Biol; 1982 Apr; 34(4):337-51. PubMed ID: 7126085
    [No Abstract]   [Full Text] [Related]  

  • 12. Failure of vasopressin to enhance memory in a passive avoidance task in rats.
    Sahgal A; Keith AB; Wright C; Edwardson JA
    Neurosci Lett; 1982 Jan; 28(1):87-92. PubMed ID: 7063145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal exposure to AVP or caffeine but not oxytocin alters learning in female rats.
    Swenson RR; Beckwith BE; Lamberty KJ; Krebs SJ; Tinius TP
    Peptides; 1990; 11(5):927-32. PubMed ID: 2284203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the avoidance learning deficit induced by the serotonin releasing compound p-chloroamphetamine.
    Ogren SO
    Brain Res Bull; 1986 May; 16(5):645-60. PubMed ID: 3742248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic-midbrain structures.
    Kovács GL; Bohus B; Versteeg DH; de Kloet ER; de Wied D
    Brain Res; 1979 Oct; 175(2):303-14. PubMed ID: 487159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facilitation of avoidance behavior by vasopressin fragments microinjected into limbic-midbrain structures.
    Kovács GL; Veldhuis HD; Versteeg DH; De Wied D
    Brain Res; 1986 Apr; 371(1):17-24. PubMed ID: 3708341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facilitation of passive avoidance response by newly synthesized cationized arginine vasopressin fragment 4-9 in rats.
    Tanabe S; Shishido Y; Furushiro M; Kado K; Hashimoto S; Yokokura T; Ohsawa T
    Pharmacol Biochem Behav; 1997; 57(1-2):251-6. PubMed ID: 9164579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central target for the behavioural effects of vasopressin neuropeptides.
    de Wied D; Gaffori O; van Ree JM; de Jong W
    Nature; 1984 Mar 15-21; 308(5956):276-8. PubMed ID: 6322010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotrophin releasing factor is more potent than some corticotrophin-related peptides in affecting passive avoidance behaviour in rats.
    Sahgal A; Wright C; Edwardson JA; Keith AB
    Neurosci Lett; 1983 Mar; 36(1):81-6. PubMed ID: 6304581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of peripherally administered arginine-vasopressin on learning, retention and forgetting in mice.
    Alescio-Lautier B; Soumireu-Mourat B
    Behav Brain Res; 1990 Dec; 41(2):117-28. PubMed ID: 2288666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.